146 related articles for article (PubMed ID: 2126028)
1. Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.
Ginsberg GM; Tulchinsky TH
J Epidemiol Community Health; 1990 Dec; 44(4):274-80. PubMed ID: 2126028
[TBL] [Abstract][Full Text] [Related]
2. Measles control in developing and developed countries: the case for a two-dose policy.
Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
[TBL] [Abstract][Full Text] [Related]
3. Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy.
Tulchinsky TH; Abed Y; Ginsberg G; Shaheen S; Friedman JB; Schoenbaum ML; Slater PE
Rev Infect Dis; 1990; 12(5):951-8. PubMed ID: 2237137
[TBL] [Abstract][Full Text] [Related]
4. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
5. Prevention of measles in Israel: short- and long-term intervention strategies.
Tulchinsky TH
Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
7. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
[TBL] [Abstract][Full Text] [Related]
8. Measles containment in Israel.
Slater PE
Isr J Med Sci; 1991 Jan; 27(1):19-21. PubMed ID: 1995495
[TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand.
Hayman DTS; Marshall JC; French NP; Carpenter TE; Roberts MG; Kiedrzynski T
Vaccine; 2017 Sep; 35(37):4913-4922. PubMed ID: 28802754
[TBL] [Abstract][Full Text] [Related]
10. Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity.
Ginsber GM; Slater PE; Shouval D
J Hepatol; 2001 Jan; 34(1):92-9. PubMed ID: 11211913
[TBL] [Abstract][Full Text] [Related]
11. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
Thompson KM; Badizadegan ND
Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
[TBL] [Abstract][Full Text] [Related]
12. [Costs and benefits of measles vaccination].
Ambrosch F; Wiedermann G; Harasek G
Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
[TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
Ginsberg GM; Shouval D
J Epidemiol Community Health; 1992 Dec; 46(6):587-94. PubMed ID: 1494073
[TBL] [Abstract][Full Text] [Related]
14. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age.
Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL
Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739
[TBL] [Abstract][Full Text] [Related]
15. The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study.
Takahashi K; Ohkusa Y; Kim JY
BMC Health Serv Res; 2011 Oct; 11():254. PubMed ID: 21978107
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
17. Measles during the Gulf War: a public health threat in Israel, the West Bank, and Gaza.
Tulchinsky TH; Belmaker I; Raabi S; Acker C; Arbeli Y; Lobel R; Abed Y; Toubassi N; Goldberg E; Slater PE
Public Health Rev; 1992-1993; 20(3-4):285-96. PubMed ID: 1343365
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
Ginsberg GM; Berger S; Shouval D
Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
[TBL] [Abstract][Full Text] [Related]
19. Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel.
Ginsberg GM; Kassis I; Dagan R
J Epidemiol Community Health; 1993 Dec; 47(6):485-90. PubMed ID: 8120505
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of supplementary immunization for measles in India.
Dabral M
Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
